Patent classifications
C07H3/06
COMPOSITION COMPRISING FUT2-DEPENDENT OLIGOSACCHARIDES AND LACTO-N-NEOTETRAOSE FOR USE IN PROMOTING BRAIN DEVELOPMENT AND COGNITION
This invention relates to the use of a nutritional composition comprising Fut2-dependent oligosaccharides for promoting brain growth and development in infants in the very early postnatal period. The nutritional composition comprises Fut2-dependent oligosaccharides and Lacto-N-neotetraose and is specifically for use in promoting brain catch-up growth in preterm infants or infants with low-birth weight. The invention further relates to a kit comprising at least two of these nutritional compositions.
Alpha (1,3) Fucosyltransferases For Use In The Production of Fucosylated Oligosaccharides
The invention relates to methods and compositions for the production of fucosylated oligosaccharides.
Alpha (1,3) Fucosyltransferases For Use In The Production of Fucosylated Oligosaccharides
The invention relates to methods and compositions for the production of fucosylated oligosaccharides.
HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS
Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood are disclosed. For example, heterobifunctional compounds that inhibit both E-selectins and CXCR4 chemokine receptors are described and pharmaceutical compositions comprising at least one of the same.
Detection of oligosaccharides
Provided herein are processes for detecting oligosaccharides in a biological sample. In specific instances, the biological sample is provided from an individual suffering from a disorder associated with abnormal glycosaminoglycan accumulation.
Detection of oligosaccharides
Provided herein are processes for detecting oligosaccharides in a biological sample. In specific instances, the biological sample is provided from an individual suffering from a disorder associated with abnormal glycosaminoglycan accumulation.
Methods and intermediates for the preparation of fondaparinux
The present invention relates to methods for the synthesis of fondaparinux and intermediates thereto.
Methods and intermediates for the preparation of fondaparinux
The present invention relates to methods for the synthesis of fondaparinux and intermediates thereto.
Compositions comprising C5 and C6 oligosaccharides
Compositions comprising C5 and C6 saccharides of varying degrees of polymerization and low levels of undesirable impurities, such as compounds containing sulfur, nitrogen, or metals, are disclosed.
Compositions comprising C5 and C6 oligosaccharides
Compositions comprising C5 and C6 saccharides of varying degrees of polymerization and low levels of undesirable impurities, such as compounds containing sulfur, nitrogen, or metals, are disclosed.